Back to mobile site

Reviva Pharmaceuticals Holdings, Inc. (RVPH) Misses Q3 EPS by 8c

November 14, 2023 5:28 PM EST

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q3 EPS of ($0.44), $0.08 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings